June 16, 2016 / 7:42 AM / in a year

BRIEF-Response Biomedical enters into agreements for going private

June 16 (Reuters) - Response Biomedical Corp :

* Says deal for cash consideration of $1.12 per response share

* Entered into a definitive arrangement agreement with 1077801 B.C. Ltd, a company owned by Orbimed Asia Partners

* Says cash consideration price represents a 51% premium to closing price of response shares

* Enters into definitive agreements for going private transaction and private placement

Source text for Eikon:

Further company coverage: (Bengaluru Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below